Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GERTZ, B. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 48

  • Page / 2
Export

Selection :

  • and

Thyroid hormone increases rat atrial natriuretic peptide messenger ribonucleic acid accumulation in vivo and in vitroGARDNER, D. G; GERTZ, B. J; HANE, S et al.Molecular endocrinology (Baltimore, Md.). 1987, Vol 1, Num 3, pp 260-265, issn 0888-8809Article

Pharmacokinetics of alendronatePORRAS, A. G; HOLLAND, S. D; GERTZ, B. J et al.Clinical pharmacokinetics. 1999, Vol 36, Num 5, pp 315-328, issn 0312-5963Article

Rationale for the use of alendronate in osteoporosisKANIS, J. A; GERTZ, B. J; SINGER, F et al.Osteoporosis international. 1995, Vol 5, Num 1, pp 1-13, issn 0937-941XArticle

Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemiaNUSSBAUM, S. R; WARRELL, R. P; GLUSMAN, J et al.Journal of clinical oncology. 1993, Vol 11, Num 8, pp 1618-1623, issn 0732-183XArticle

The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humansMURPHY, M. G; SYTNIK, B; KOVACS, T. O. G et al.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 5, pp 533-539, issn 0009-9236Article

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans: implications for the physiology of CCKLIDDLE, R. A; GERTZ, B. J; KANAYAMA, S et al.The Journal of clinical investigation. 1989, Vol 84, Num 4, pp 1220-1225, issn 0021-9738Article

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt dietSCHWARTZ, J. I; VANDORMAEL, K; BRUNE, K et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 1, pp 50-61, issn 0009-9236Article

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonistNAVARI, R. M; REINHARDT, R. R; CARIDES, A. D et al.The New England journal of medicine. 1999, Vol 340, Num 3, pp 190-195, issn 0028-4793Article

Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young menKIRK, S. E; GERTZ, B. J; SCHNEIDER, S. H et al.The Journal of clinical endocrinology and metabolism. 1997, Vol 82, Num 4, pp 1154-1159, issn 0021-972XArticle

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosisKHAN, S. A; KANIS, J. A; ORGEE, J et al.Journal of bone and mineral research (Print). 1997, Vol 12, Num 10, pp 1700-1707, issn 0884-0431Article

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal womenHARRIS, S. T; GERTZ, B. J; GENANT, H. K et al.The Journal of clinical endocrinology and metabolism. 1993, Vol 76, Num 6, pp 1399-1406, issn 0021-972XArticle

Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitusJAVIER ORTIZ-ALONSO, F; HERMAN, W. H; GERTZ, B. J et al.Metabolism, clinical and experimental. 1991, Vol 40, Num 11, pp 1160-1167, issn 0026-0495Article

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritisGOTTESDIENER, K; SCHNITZER, T; FISHER, C et al.Rheumatology (Oxford. Print). 2002, Vol 41, Num 9, pp 1052-1061, issn 1462-0324Article

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesisCOCQUYT, V; VAN BELLE, S; CARIDES, A. D et al.European journal of cancer (1990). 2001, Vol 37, Num 7, pp 835-842, issn 0959-8049Article

Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic womenMURPHY, M. G; WEISS, S; MCCLUNG, M et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 3, pp 1116-1125, issn 0021-972XArticle

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humansDEPRE, M; EHRICH, E; VAN HECKEN, A et al.European journal of clinical pharmacology. 2000, Vol 56, Num 2, pp 167-174, issn 0031-6970Article

Dose-response relationships for alendronate treatment in osteoporotic elderly womenBONE, H. G; DOWNS, R. W; POLVINO, W. J et al.The Journal of clinical endocrinology and metabolism. 1997, Vol 82, Num 1, pp 265-274, issn 0021-972XArticle

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritisGINEYTS, E; MO, J. A; KO, A et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 7, pp 857-861, issn 0003-4967, 5 p.Article

Substance P-induced vasodilatation is mediated by the neurokinin type I receptor but does not contribute to basal vascular tone in manNEWBY, D. E; SCIBERRAS, D. G; FERRO, C. J et al.British journal of clinical pharmacology. 1999, Vol 48, Num 3, pp 336-344, issn 0306-5251Article

Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adultsMURPHY, M. G; BACH, M. A; PLOTKIN, D et al.Journal of bone and mineral research (Print). 1999, Vol 14, Num 7, pp 1182-1188, issn 0884-0431Article

Studies of the oral bioavailability of alendronateGERTZ, B. J; HOLLAND, S. D; KLINE, W. F et al.Clinical pharmacology and therapeutics. 1995, Vol 58, Num 3, pp 288-298, issn 0009-9236Article

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urineGERTZ, B. J; SHAO, P; HANSON, D. A et al.Journal of bone and mineral research (Print). 1994, Vol 9, Num 2, pp 135-142, issn 0884-0431Article

Regulation of pancreatic endocrine function by cholecystokinin : studies with MK-329, a nonpeptide cholecystokinin receptor antagonistLIDDLE, R. A; GERTZ, B. J; KANAYAMA, S et al.The Journal of clinical endocrinology and metabolism. 1990, Vol 70, Num 5, pp 1312-1318, issn 0021-972X, 7 p.Article

A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathyMENDEL, C. M; KLEIN, R. F; CHAPPELL, D. A et al.JAMA, the journal of the American Medical Association. 1986, Vol 255, Num 5, pp 637-639, issn 0098-7484Article

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet : A randomized, controlled trialSWAN, S. K; RUDY, D. W; GUMBS, C. P et al.Annals of internal medicine. 2000, Vol 133, Num 1, pp 1-9, issn 0003-4819Article

  • Page / 2